ROGELIO AVELAR: Open Payments
NPI 1932889250 · BONITA SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,612 in 74 payments from 19 companies in 2025. Trend: 2023 $317 · 2024 $1,257 · 2025 $1,612
Food & beverage: $1,612
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $336 |
| Sumitomo Pharma America, Inc. | 13 | $205 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $158 |
| Boston Scientific Corporation | 2 | $149 |
| UROGEN PHARMA, INC. | 3 | $95 |
| Astellas Pharma US Inc | 4 | $89 |
| COLOPLAST CORP | 4 | $85 |
| Endo USA, Inc. | 3 | $79 |
| Teleflex LLC | 3 | $70 |
| Ferring Pharmaceuticals Inc. | 2 | $65 |
Products named: ERLEADA, Nubeqa, Axonics, RYBREVANT, GEMTESA, Xtandi, ORGOVYX, AVEED.
Industry payments across FL — which companies pay providers there.
